Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 28.7T | 28.4T | 28.4T | 26.8T |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.7T | 4.6T | 3.3T | 2.9T |
Other operating expenses | 1.1T | 980.7B | 1.0T | 804.9B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 17.5T | 17.4T | 17.6T | 17.3T |
Tax provision | 3.3T | 3.6T | 3.4T | 3.3T |
Net income | 14.1T | 13.8T | 14.2T | 14.0T |
Basic EPS | 115 | — | — | — |
Diluted EPS | 115 | — | — | — |
Basic average shares | 123.3B | — | — | — |
Diluted average shares | 123.3B | — | — | — |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | -859M | -943M | -12.7B | -2.3B |
Preferred stock dividends | — | — | — | — |